Table 3.

Current risk-predicting scores of hepatocellular carcinoma development in chronic hepatitis B patients with antiviral therapy

Predicting scores	Predictors	5-year AUROC to predict HCC risk
PAGE-B [122]	Age, male, platelet	0.82
mPAGE-B [123]	Age, male, platelet, albumin	0.82
HCC-RESCUE [124]	Age, male, cirrhosis	0.77
APA-B [125]	Age, platelet, alpha-fetoprotein	0.827
CAMD [126]	Age, male, cirrhosis, diabetes	0.76
AASL-HCC [127]	Age, male, albumin, cirrhosis	0.802
REAL-B [128]	Age, male, alcohol use, diabetes, cirrhosis, platelet, alpha- fetoprotein	0.80

AUROC, area under receiver operating characteristic; HCC, hepatocellular carcinoma.